EGM
STOK icon

Engineers Gate Manager’s Stoke Therapeutics STOK Stock Holding History

Engineers Gate Manager’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-33,276
Closed -$378K – 2511
2025
Q2 		$378K Buy
+33,276
New +$316K ﹤0.01% 1615
2025
Q1 		– Sell
-25,005
Closed -$276K – 2570
2024
Q4 		$276K Buy
25,005
+800
+3% +$9.83K ﹤0.01% 1741
2024
Q3 		$297K Sell
24,205
-3,719
-13% -$52.7K 0.01% 1624
2024
Q2 		$377K Buy
+27,924
New +$377K 0.01% 1351
2022
Q2 		– Sell
-9,958
Closed -$210K – 2249
2022
Q1 		$210K Buy
+9,958
New +$199K 0.01% 1601

Other funds holding STOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return

Engineers Gate Manager's STOK Position: Q3 2025 in Review

Engineers Gate Manager sold out of Stoke Therapeutics (STOK) in Q3 2025, closing a stake of 33,276 shares — an estimated $378K sold.

Engineers Gate Manager first reported a position in STOK in Q1 2022 and held it in 5 quarters. The position peaked at $378K in Q2 2025. 151 funds tracked by Wall St. Rank hold STOK as of Q3 2025.

  • Engineers Gate Manager reported no remaining Stoke Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 33,276 Stoke Therapeutics shares in Q3 2025, an estimated $378K.
  • Engineers Gate Manager first reported a position in Stoke Therapeutics in Q1 2022 and held it in 5 quarters.
  • Engineers Gate Manager's Stoke Therapeutics position peaked at $378K in Q2 2025.
  • 151 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2025.

Based on Engineers Gate Manager's 13F filing for Q3 2025, filed 14 Nov 2025.